Levofloxacin

Product manufactured by Akorn Inc.

Application Nr Approved Date Route Status External Links
ANDA090268 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Levofloxacin Ophthalmic Solution Is Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Strains Of The Following Organisms: Gram-Positive Bacteria Corynebacterium Species* Staphylococcus Aureus Staphylococcus Epidermidis Streptococcus Pneumonia Streptococcus (Groups C/f) Streptococcus (Group G) Viridans Group Streptococci* Gram-Negative Bacteria Acinetobacter Lwoffii* Haemophilus Influenzae Serratia Marcescens* * Efficacy For This Organism Was Studied In Fewer Than 10 Infections. Levofloxacin Ophthalmic Solution Is Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Strains Of The Following Organisms: Gram-Positive Bacteria Corynebacterium Species* Staphylococcus Aureus Staphylococcus Epidermidis Streptococcus Pneumonia Streptococcus (Groups C/f) Streptococcus (Group G) Viridans Group Streptococci* Gram-Negative Bacteria Acinetobacter Lwoffii* Haemophilus Influenzae Serratia Marcescens* * Efficacy For This Organism Was Studied In Fewer Than 10 Infections ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levofloxacin LEVOFLOXACIN ZINC538273

Comments